Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the incidence of rate control (defined as:
HR <110 beats/min or conversion to sinus rhythm) at 2 hours after medication administration
between oral immediate release diltiazem and intravenous continuous infusion diltiazem.